Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2023-2029

Page: 113

Published Date: 14 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Peripheral Vasodilator Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.

This report studies the global Peripheral Vasodilator Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Peripheral Vasodilator Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peripheral Vasodilator Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Peripheral Vasodilator Drugs total production and demand, 2018-2029, (K Units)
Global Peripheral Vasodilator Drugs total production value, 2018-2029, (USD Million)
Global Peripheral Vasodilator Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Peripheral Vasodilator Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Peripheral Vasodilator Drugs domestic production, consumption, key domestic manufacturers and share
Global Peripheral Vasodilator Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Peripheral Vasodilator Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Peripheral Vasodilator Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Peripheral Vasodilator Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Inc., Novartis AG, GSK plc, AstraZeneca, Merck & Co., Inc., Sanofi, Bayer AG, Abbott Laboratories and Bristol-Myers Squibb Company, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Peripheral Vasodilator Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Peripheral Vasodilator Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Peripheral Vasodilator Drugs Market, Segmentation by Type
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Others

Global Peripheral Vasodilator Drugs Market, Segmentation by Application
Hospital
Retail Pharmacies
Others

Companies Profiled:
Pfizer, Inc.
Novartis AG
GSK plc
AstraZeneca
Merck & Co., Inc.
Sanofi
Bayer AG
Abbott Laboratories
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
Sun Pharmaceutical Industries Ltd.
Lupin

Key Questions Answered
1. How big is the global Peripheral Vasodilator Drugs market?
2. What is the demand of the global Peripheral Vasodilator Drugs market?
3. What is the year over year growth of the global Peripheral Vasodilator Drugs market?
4. What is the production and production value of the global Peripheral Vasodilator Drugs market?
5. Who are the key producers in the global Peripheral Vasodilator Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Peripheral Vasodilator Drugs Introduction
    1.2 World Peripheral Vasodilator Drugs Supply & Forecast
        1.2.1 World Peripheral Vasodilator Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Peripheral Vasodilator Drugs Production (2018-2029)
        1.2.3 World Peripheral Vasodilator Drugs Pricing Trends (2018-2029)
    1.3 World Peripheral Vasodilator Drugs Production by Region (Based on Production Site)
        1.3.1 World Peripheral Vasodilator Drugs Production Value by Region (2018-2029)
        1.3.2 World Peripheral Vasodilator Drugs Production by Region (2018-2029)
        1.3.3 World Peripheral Vasodilator Drugs Average Price by Region (2018-2029)
        1.3.4 North America Peripheral Vasodilator Drugs Production (2018-2029)
        1.3.5 Europe Peripheral Vasodilator Drugs Production (2018-2029)
        1.3.6 China Peripheral Vasodilator Drugs Production (2018-2029)
        1.3.7 Japan Peripheral Vasodilator Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Peripheral Vasodilator Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Peripheral Vasodilator Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Peripheral Vasodilator Drugs Demand (2018-2029)
    2.2 World Peripheral Vasodilator Drugs Consumption by Region
        2.2.1 World Peripheral Vasodilator Drugs Consumption by Region (2018-2023)
        2.2.2 World Peripheral Vasodilator Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Peripheral Vasodilator Drugs Consumption (2018-2029)
    2.4 China Peripheral Vasodilator Drugs Consumption (2018-2029)
    2.5 Europe Peripheral Vasodilator Drugs Consumption (2018-2029)
    2.6 Japan Peripheral Vasodilator Drugs Consumption (2018-2029)
    2.7 South Korea Peripheral Vasodilator Drugs Consumption (2018-2029)
    2.8 ASEAN Peripheral Vasodilator Drugs Consumption (2018-2029)
    2.9 India Peripheral Vasodilator Drugs Consumption (2018-2029)

3 World Peripheral Vasodilator Drugs Manufacturers Competitive Analysis
    3.1 World Peripheral Vasodilator Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Peripheral Vasodilator Drugs Production by Manufacturer (2018-2023)
    3.3 World Peripheral Vasodilator Drugs Average Price by Manufacturer (2018-2023)
    3.4 Peripheral Vasodilator Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Peripheral Vasodilator Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Peripheral Vasodilator Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Peripheral Vasodilator Drugs in 2022
    3.6 Peripheral Vasodilator Drugs Market: Overall Company Footprint Analysis
        3.6.1 Peripheral Vasodilator Drugs Market: Region Footprint
        3.6.2 Peripheral Vasodilator Drugs Market: Company Product Type Footprint
        3.6.3 Peripheral Vasodilator Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Peripheral Vasodilator Drugs Production Value Comparison
        4.1.1 United States VS China: Peripheral Vasodilator Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Peripheral Vasodilator Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Peripheral Vasodilator Drugs Production Comparison
        4.2.1 United States VS China: Peripheral Vasodilator Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Peripheral Vasodilator Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Peripheral Vasodilator Drugs Consumption Comparison
        4.3.1 United States VS China: Peripheral Vasodilator Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Peripheral Vasodilator Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Peripheral Vasodilator Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Peripheral Vasodilator Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Peripheral Vasodilator Drugs Production (2018-2023)
    4.5 China Based Peripheral Vasodilator Drugs Manufacturers and Market Share
        4.5.1 China Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Peripheral Vasodilator Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Peripheral Vasodilator Drugs Production (2018-2023)
    4.6 Rest of World Based Peripheral Vasodilator Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Peripheral Vasodilator Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Calcium Channel Blockers
        5.2.2 Alpha-adrenergic Blockers
        5.2.3 Potassium Channel Activators
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Peripheral Vasodilator Drugs Production by Type (2018-2029)
        5.3.2 World Peripheral Vasodilator Drugs Production Value by Type (2018-2029)
        5.3.3 World Peripheral Vasodilator Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Peripheral Vasodilator Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacies
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Peripheral Vasodilator Drugs Production by Application (2018-2029)
        6.3.2 World Peripheral Vasodilator Drugs Production Value by Application (2018-2029)
        6.3.3 World Peripheral Vasodilator Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer, Inc.
        7.1.1 Pfizer, Inc. Details
        7.1.2 Pfizer, Inc. Major Business
        7.1.3 Pfizer, Inc. Peripheral Vasodilator Drugs Product and Services
        7.1.4 Pfizer, Inc. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer, Inc. Recent Developments/Updates
        7.1.6 Pfizer, Inc. Competitive Strengths & Weaknesses
    7.2 Novartis AG
        7.2.1 Novartis AG Details
        7.2.2 Novartis AG Major Business
        7.2.3 Novartis AG Peripheral Vasodilator Drugs Product and Services
        7.2.4 Novartis AG Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis AG Recent Developments/Updates
        7.2.6 Novartis AG Competitive Strengths & Weaknesses
    7.3 GSK plc
        7.3.1 GSK plc Details
        7.3.2 GSK plc Major Business
        7.3.3 GSK plc Peripheral Vasodilator Drugs Product and Services
        7.3.4 GSK plc Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GSK plc Recent Developments/Updates
        7.3.6 GSK plc Competitive Strengths & Weaknesses
    7.4 AstraZeneca
        7.4.1 AstraZeneca Details
        7.4.2 AstraZeneca Major Business
        7.4.3 AstraZeneca Peripheral Vasodilator Drugs Product and Services
        7.4.4 AstraZeneca Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 AstraZeneca Recent Developments/Updates
        7.4.6 AstraZeneca Competitive Strengths & Weaknesses
    7.5 Merck & Co., Inc.
        7.5.1 Merck & Co., Inc. Details
        7.5.2 Merck & Co., Inc. Major Business
        7.5.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Product and Services
        7.5.4 Merck & Co., Inc. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Merck & Co., Inc. Recent Developments/Updates
        7.5.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
    7.6 Sanofi
        7.6.1 Sanofi Details
        7.6.2 Sanofi Major Business
        7.6.3 Sanofi Peripheral Vasodilator Drugs Product and Services
        7.6.4 Sanofi Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Sanofi Recent Developments/Updates
        7.6.6 Sanofi Competitive Strengths & Weaknesses
    7.7 Bayer AG
        7.7.1 Bayer AG Details
        7.7.2 Bayer AG Major Business
        7.7.3 Bayer AG Peripheral Vasodilator Drugs Product and Services
        7.7.4 Bayer AG Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Bayer AG Recent Developments/Updates
        7.7.6 Bayer AG Competitive Strengths & Weaknesses
    7.8 Abbott Laboratories
        7.8.1 Abbott Laboratories Details
        7.8.2 Abbott Laboratories Major Business
        7.8.3 Abbott Laboratories Peripheral Vasodilator Drugs Product and Services
        7.8.4 Abbott Laboratories Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Abbott Laboratories Recent Developments/Updates
        7.8.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.9 Bristol-Myers Squibb Company
        7.9.1 Bristol-Myers Squibb Company Details
        7.9.2 Bristol-Myers Squibb Company Major Business
        7.9.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product and Services
        7.9.4 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Bristol-Myers Squibb Company Recent Developments/Updates
        7.9.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    7.10 Boehringer Ingelheim International GmbH
        7.10.1 Boehringer Ingelheim International GmbH Details
        7.10.2 Boehringer Ingelheim International GmbH Major Business
        7.10.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product and Services
        7.10.4 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
        7.10.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
    7.11 Teva Pharmaceutical Industries Ltd.
        7.11.1 Teva Pharmaceutical Industries Ltd. Details
        7.11.2 Teva Pharmaceutical Industries Ltd. Major Business
        7.11.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
        7.11.4 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
        7.11.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
    7.12 Viatris, Inc.
        7.12.1 Viatris, Inc. Details
        7.12.2 Viatris, Inc. Major Business
        7.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Product and Services
        7.12.4 Viatris, Inc. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Viatris, Inc. Recent Developments/Updates
        7.12.6 Viatris, Inc. Competitive Strengths & Weaknesses
    7.13 Sun Pharmaceutical Industries Ltd.
        7.13.1 Sun Pharmaceutical Industries Ltd. Details
        7.13.2 Sun Pharmaceutical Industries Ltd. Major Business
        7.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
        7.13.4 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
        7.13.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
    7.14 Lupin
        7.14.1 Lupin Details
        7.14.2 Lupin Major Business
        7.14.3 Lupin Peripheral Vasodilator Drugs Product and Services
        7.14.4 Lupin Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Lupin Recent Developments/Updates
        7.14.6 Lupin Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Peripheral Vasodilator Drugs Industry Chain
    8.2 Peripheral Vasodilator Drugs Upstream Analysis
        8.2.1 Peripheral Vasodilator Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Peripheral Vasodilator Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Peripheral Vasodilator Drugs Production Mode
    8.6 Peripheral Vasodilator Drugs Procurement Model
    8.7 Peripheral Vasodilator Drugs Industry Sales Model and Sales Channels
        8.7.1 Peripheral Vasodilator Drugs Sales Model
        8.7.2 Peripheral Vasodilator Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Peripheral Vasodilator Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Peripheral Vasodilator Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Peripheral Vasodilator Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Peripheral Vasodilator Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Peripheral Vasodilator Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Peripheral Vasodilator Drugs Production by Region (2018-2023) & (K Units)
    Table 7. World Peripheral Vasodilator Drugs Production by Region (2024-2029) & (K Units)
    Table 8. World Peripheral Vasodilator Drugs Production Market Share by Region (2018-2023)
    Table 9. World Peripheral Vasodilator Drugs Production Market Share by Region (2024-2029)
    Table 10. World Peripheral Vasodilator Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Peripheral Vasodilator Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Peripheral Vasodilator Drugs Major Market Trends
    Table 13. World Peripheral Vasodilator Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Peripheral Vasodilator Drugs Consumption by Region (2018-2023) & (K Units)
    Table 15. World Peripheral Vasodilator Drugs Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Peripheral Vasodilator Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Peripheral Vasodilator Drugs Producers in 2022
    Table 18. World Peripheral Vasodilator Drugs Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Peripheral Vasodilator Drugs Producers in 2022
    Table 20. World Peripheral Vasodilator Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Peripheral Vasodilator Drugs Company Evaluation Quadrant
    Table 22. World Peripheral Vasodilator Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Peripheral Vasodilator Drugs Production Site of Key Manufacturer
    Table 24. Peripheral Vasodilator Drugs Market: Company Product Type Footprint
    Table 25. Peripheral Vasodilator Drugs Market: Company Product Application Footprint
    Table 26. Peripheral Vasodilator Drugs Competitive Factors
    Table 27. Peripheral Vasodilator Drugs New Entrant and Capacity Expansion Plans
    Table 28. Peripheral Vasodilator Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Peripheral Vasodilator Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Peripheral Vasodilator Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Peripheral Vasodilator Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Peripheral Vasodilator Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Peripheral Vasodilator Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Peripheral Vasodilator Drugs Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Peripheral Vasodilator Drugs Production Market Share (2018-2023)
    Table 37. China Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Peripheral Vasodilator Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Peripheral Vasodilator Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Peripheral Vasodilator Drugs Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Peripheral Vasodilator Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Market Share (2018-2023)
    Table 47. World Peripheral Vasodilator Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Peripheral Vasodilator Drugs Production by Type (2018-2023) & (K Units)
    Table 49. World Peripheral Vasodilator Drugs Production by Type (2024-2029) & (K Units)
    Table 50. World Peripheral Vasodilator Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Peripheral Vasodilator Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Peripheral Vasodilator Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Peripheral Vasodilator Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Peripheral Vasodilator Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Peripheral Vasodilator Drugs Production by Application (2018-2023) & (K Units)
    Table 56. World Peripheral Vasodilator Drugs Production by Application (2024-2029) & (K Units)
    Table 57. World Peripheral Vasodilator Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Peripheral Vasodilator Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Peripheral Vasodilator Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Peripheral Vasodilator Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
    Table 62. Pfizer, Inc. Major Business
    Table 63. Pfizer, Inc. Peripheral Vasodilator Drugs Product and Services
    Table 64. Pfizer, Inc. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Pfizer, Inc. Recent Developments/Updates
    Table 66. Pfizer, Inc. Competitive Strengths & Weaknesses
    Table 67. Novartis AG Basic Information, Manufacturing Base and Competitors
    Table 68. Novartis AG Major Business
    Table 69. Novartis AG Peripheral Vasodilator Drugs Product and Services
    Table 70. Novartis AG Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Novartis AG Recent Developments/Updates
    Table 72. Novartis AG Competitive Strengths & Weaknesses
    Table 73. GSK plc Basic Information, Manufacturing Base and Competitors
    Table 74. GSK plc Major Business
    Table 75. GSK plc Peripheral Vasodilator Drugs Product and Services
    Table 76. GSK plc Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GSK plc Recent Developments/Updates
    Table 78. GSK plc Competitive Strengths & Weaknesses
    Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 80. AstraZeneca Major Business
    Table 81. AstraZeneca Peripheral Vasodilator Drugs Product and Services
    Table 82. AstraZeneca Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. AstraZeneca Recent Developments/Updates
    Table 84. AstraZeneca Competitive Strengths & Weaknesses
    Table 85. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
    Table 86. Merck & Co., Inc. Major Business
    Table 87. Merck & Co., Inc. Peripheral Vasodilator Drugs Product and Services
    Table 88. Merck & Co., Inc. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Merck & Co., Inc. Recent Developments/Updates
    Table 90. Merck & Co., Inc. Competitive Strengths & Weaknesses
    Table 91. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 92. Sanofi Major Business
    Table 93. Sanofi Peripheral Vasodilator Drugs Product and Services
    Table 94. Sanofi Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Sanofi Recent Developments/Updates
    Table 96. Sanofi Competitive Strengths & Weaknesses
    Table 97. Bayer AG Basic Information, Manufacturing Base and Competitors
    Table 98. Bayer AG Major Business
    Table 99. Bayer AG Peripheral Vasodilator Drugs Product and Services
    Table 100. Bayer AG Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Bayer AG Recent Developments/Updates
    Table 102. Bayer AG Competitive Strengths & Weaknesses
    Table 103. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
    Table 104. Abbott Laboratories Major Business
    Table 105. Abbott Laboratories Peripheral Vasodilator Drugs Product and Services
    Table 106. Abbott Laboratories Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Abbott Laboratories Recent Developments/Updates
    Table 108. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 109. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
    Table 110. Bristol-Myers Squibb Company Major Business
    Table 111. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product and Services
    Table 112. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Bristol-Myers Squibb Company Recent Developments/Updates
    Table 114. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    Table 115. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
    Table 116. Boehringer Ingelheim International GmbH Major Business
    Table 117. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product and Services
    Table 118. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Boehringer Ingelheim International GmbH Recent Developments/Updates
    Table 120. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
    Table 121. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
    Table 122. Teva Pharmaceutical Industries Ltd. Major Business
    Table 123. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
    Table 124. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
    Table 126. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
    Table 127. Viatris, Inc. Basic Information, Manufacturing Base and Competitors
    Table 128. Viatris, Inc. Major Business
    Table 129. Viatris, Inc. Peripheral Vasodilator Drugs Product and Services
    Table 130. Viatris, Inc. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Viatris, Inc. Recent Developments/Updates
    Table 132. Viatris, Inc. Competitive Strengths & Weaknesses
    Table 133. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
    Table 134. Sun Pharmaceutical Industries Ltd. Major Business
    Table 135. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
    Table 136. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
    Table 138. Lupin Basic Information, Manufacturing Base and Competitors
    Table 139. Lupin Major Business
    Table 140. Lupin Peripheral Vasodilator Drugs Product and Services
    Table 141. Lupin Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 142. Global Key Players of Peripheral Vasodilator Drugs Upstream (Raw Materials)
    Table 143. Peripheral Vasodilator Drugs Typical Customers
    Table 144. Peripheral Vasodilator Drugs Typical Distributors
List of Figure
    Figure 1. Peripheral Vasodilator Drugs Picture
    Figure 2. World Peripheral Vasodilator Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Peripheral Vasodilator Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Peripheral Vasodilator Drugs Production (2018-2029) & (K Units)
    Figure 5. World Peripheral Vasodilator Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Peripheral Vasodilator Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Peripheral Vasodilator Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Peripheral Vasodilator Drugs Production (2018-2029) & (K Units)
    Figure 9. Europe Peripheral Vasodilator Drugs Production (2018-2029) & (K Units)
    Figure 10. China Peripheral Vasodilator Drugs Production (2018-2029) & (K Units)
    Figure 11. Japan Peripheral Vasodilator Drugs Production (2018-2029) & (K Units)
    Figure 12. Peripheral Vasodilator Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 15. World Peripheral Vasodilator Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 17. China Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 18. Europe Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 19. Japan Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 22. India Peripheral Vasodilator Drugs Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Peripheral Vasodilator Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Peripheral Vasodilator Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Peripheral Vasodilator Drugs Markets in 2022
    Figure 26. United States VS China: Peripheral Vasodilator Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Peripheral Vasodilator Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Peripheral Vasodilator Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Peripheral Vasodilator Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Peripheral Vasodilator Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Market Share 2022
    Figure 32. World Peripheral Vasodilator Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Peripheral Vasodilator Drugs Production Value Market Share by Type in 2022
    Figure 34. Calcium Channel Blockers
    Figure 35. Alpha-adrenergic Blockers
    Figure 36. Potassium Channel Activators
    Figure 37. Others
    Figure 38. World Peripheral Vasodilator Drugs Production Market Share by Type (2018-2029)
    Figure 39. World Peripheral Vasodilator Drugs Production Value Market Share by Type (2018-2029)
    Figure 40. World Peripheral Vasodilator Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Peripheral Vasodilator Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Peripheral Vasodilator Drugs Production Value Market Share by Application in 2022
    Figure 43. Hospital
    Figure 44. Retail Pharmacies
    Figure 45. Others
    Figure 46. World Peripheral Vasodilator Drugs Production Market Share by Application (2018-2029)
    Figure 47. World Peripheral Vasodilator Drugs Production Value Market Share by Application (2018-2029)
    Figure 48. World Peripheral Vasodilator Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Peripheral Vasodilator Drugs Industry Chain
    Figure 50. Peripheral Vasodilator Drugs Procurement Model
    Figure 51. Peripheral Vasodilator Drugs Sales Model
    Figure 52. Peripheral Vasodilator Drugs Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Peripheral Vasodilator Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Peripheral Vasodilator Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 14 Mar 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peripheral Vasodilator Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2024-2030

Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2024-2030

date 12 Feb 2024

date Pharma & Healthcare

The global Peripheral Vasodilator Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Peripheral Vasodilator Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>